Survival Outcomes in Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis of Progression-Related Endpoints
Cancers · 23.05.2026 · 18 (11) · 1705
DOI: 10.3390/cancers18111705 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 23.05.2026. Verfasst von Lavinia Simona Neculai-Candea und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Medicine, "Sf. Apostol Andrei" Emergency County Hospital, 900439 Constanta, Romania. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pancreatic neuroendocrine tumors (pNETs) represent a heterogeneous group of neoplasms characterized by variable biological behavior and clinical outcomes. Multiple therapeutic strategies have been investigated, including surgery, targeted therapies, peptide receptor radionuclide therapy, and systemic treatments. The present study aimed to summarize survival-related outcomes reported across studies investigating the management of pNETs.
Methods
A systematic review of the literature was conducted including studies reporting clinical outcomes in patients with pancreatic neuroendocrine tumors. A total of 27 studies were included in the qualitative analysis. Survival-related outcomes, such as progression-free survival (PFS), recurrence-free survival (RFS), and recurrence rates, were extracted. Studies reporting quantitative survival values were included in the meta-analytical component. A random-effects model was applied, and a forest plot was generated to summarize the reported outcomes.
Results
Reported survival outcomes varied substantially across studies. Median PFS values ranged from approximately 5.6 to 86.5 months, while several surgical series reported 5-year overall survival rates exceeding 90%. Recurrence rates following surgical resection ranged from approximately 12% to 26% in some cohorts. The pooled estimate derived from the meta-analytical model was 32.22 (95% CI: 15.65–48.80).
Conclusions
The analysis summarizes survival-related outcomes reported in studies investigating pancreatic neuroendocrine tumors and provides a quantitative overview of the reported progression-related endpoints across the analyzed literature.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Forensic Medicine, "Sf. Apostol Andrei" Emergency County Hospital, 900439 Constanta, Romania.
- Legal Medicine Pre-Clinics Department, University Ovidius Constanta, 905900 Constanta, Romania.
- Department of Oncology and Hematology, Faculty of Medicine, Ovidius Clinical Hospital, University Ovidius Constanta, 905900 Constanta, Romania.
- Department of Histology, University Ovidius Constanta, 905900 Constanta, Romania.
- Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology-CEDMOG, "Ovidius" University of Constanta, 900470 Constanta, Romania.
- Department of Pathology, St. Vincent's University Hospital, Elm Park, D04 T6F4 Dublin, Ireland.
ORCID-Profile: Andreea-Daniela Caloian, Sorin Deacu, Miruna Cristian, Laura Mazilu, Nicolae Ciufu
Zitieren
APA
Neculai-Candea, L. S., Caloian, A. D., Deacu, S., Cristian, M., Mazilu, L., Ilie-Petrov, A. C., Nitu, R. A., Ciufu, C. A., & Ciufu, N. (2026). Survival Outcomes in Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis of Progression-Related Endpoints. Cancers, 18(11), 1705. https://doi.org/10.3390/cancers18111705
Vancouver
Neculai-Candea LS, Caloian AD, Deacu S, Cristian M, Mazilu L, Ilie-Petrov AC, et al. Survival Outcomes in Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis of Progression-Related Endpoints. Cancers. 2026;18(11):1705. doi:10.3390/cancers18111705
BibTeX
@article{NeculaiCandea2026,
author = {Neculai-Candea, Lavinia Simona and Caloian, Andreea-Daniela and Deacu, Sorin and Cristian, Miruna and Mazilu, Laura and Ilie-Petrov, Andreea-Corina and Nitu, Radu Adrian and Ciufu, Carmen Aida and Ciufu, Nicolae},
title = {Survival Outcomes in Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis of Progression-Related Endpoints},
journal = {Cancers},
year = {2026},
volume = {18},
number = {11},
pages = {1705},
doi = {10.3390/cancers18111705}
}
EUVIMED